SN

Smitha Nanjundaswamy Gujjar

Active Director Director DIN 10057668
DIN 10057668 First appointment Feb 2023 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Smitha Nanjundaswamy Gujjar

Data last updated:

Smitha Nanjundaswamy Gujjar is a Director at Vishruta Hospital Private Limited (since 2023). The company operates in Healthcare.

DIN 10057668
Primary Designation Director
Industry Healthcare
First Appointment 27 Feb 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Vishruta Hospital Private Limited U86909KA2023PTC170870
Director27 Feb 20232023Active

Board colleagues of Smitha Nanjundaswamy Gujjar

NameDINCompanyDesignation
Somashekar10057669Vishruta Hospital Private LimitedDirector

Directorship timeline

Open interactive timeline →
Vishruta Hospital Private Limited
Premium access

Shareholding and investment profile for Smitha Nanjundaswamy Gujjar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Smitha Nanjundaswamy Gujjar

Smitha Nanjundaswamy Gujjar currently holds 1 directorship: Vishruta Hospital Private Limited (Director, since 27 Feb 2023).

Smitha Nanjundaswamy Gujjar was first appointed on 27 Feb 2023 as Director at Vishruta Hospital Private Limited.

The current boards of Smitha Nanjundaswamy Gujjar's companies include Somashekar (Vishruta Hospital Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available